Sativa Board

Latest articles

ANNOUNCEMENT: One Day Extension for Publication of Scheme Document

Further to the announcement made by the Company on 23 June 2020, Sativa Group Plc, the UK’s leading quoted CBD wellness and medicinal cannabis Group, announces that it and StillCanna Inc have agreed to extend the date by which the Scheme Document must be posted to Sativa Shareholders until tomorrow, 22 July 2020.

ANNOUNCEMENT: Record Month at Sativa

Sativa Group Plc [AQSE: SATI], the UK’s leading quoted CBD wellness and medicinal cannabis company, has recorded a record month of revenues for the Group in June.
Record sales have been achieved in the month of June through a combination of both CBD and Hand Sanitiser sales from the Goodbody brand, comprising Goodbody Botanicals and Goodbody Wellness.

ANNOUNCEMENT: Food Standards Agency (FSA) Regulations

Sativa Group Plc [AQSE: SATI], the UK’s leading quoted CBD wellness and medicinal cannabis Group, is working on its Novel Food application in partnership with Stillcanna Inc, and is committed to meeting the requirements of the Food Standards Agency (“FSA”) concerning the safe use of CBD products and the timetable for Novel Food authorisation.

ANNOUNCEMENT: Grant of Options

Sativa Group Plc (AQSE: SATI), the UK’s leading quoted CBD wellness and medicinal cannabis company, announces that certain options having reverted back to Geremy Thomas from former employees of the Group, having lapsed due to vesting conditions not having been met, have been re-surrended so that 3,076,923 options have been issued to Joseph Colliver, Chief Financial Officer of Sativa, and 1,333,333 options have been issued to Anne Tew, Company Secretary of Sativa.

ANNOUNCEMENT: Notice of Convening Hearing

Further to the announcement made by the Company on 3 June 2020 (the “Rule 2.7 Announcement”), Sativa Group Plc, the UK’s leading quoted CBD wellness and medicinal cannabis Group, confirms that is has yesterday, 22 June, issued a Part 8 Claim Form dated 22 June 2020 in the Companies Court for an Order under Section 896 of the Companies Act 2006 to convene on 14 August 2020 at 11 a.m…

ANNOUNCEMENT: Resumption of Share Trading

Sativa Group Plc (AQSE: SATI), the UK’s leading quoted CBD wellness and medicinal cannabis company, is pleased to announce the resumption of share trading in the Company’s Ordinary Shares is due to recommence. The shares were suspended pending a firm intention to make an offer from StillCanna Inc. The Scheme of Arrangement terms have now been agreed…

ANNOUNCEMENT: Management Incentive Plan (“MIP”)

Sativa Group Plc (AQSE: SATI), (or “Sativa” or “the Company” or “the Group”), the UK’s leading quoted CBD wellness and medicinal cannabis company, is pleased to announce the implementation of a new management incentive plan (“MIP”) to retain and incentivise Henry Lees-Buckley, Chief Executive Officer, and to replace the existing options held by certain Directors of Sativa.

ANNOUNCEMENT: RECOMMENDED ALL-SHARE OFFER by STILLCANNA INC

• Further to the announcements made on 22 April 2020 and 20 May 2020, the boards of directors of Stillcanna Inc. (“Stillcanna”) and Sativa Group plc (“Sativa” or the “Company”) are pleased to announce that they have reached agreement on the terms of a recommended share for share exchange offer to be made by Stillcanna for the entire issued and to be issued share capital of Sativa (the “Offer”).

ANNOUNCEMENT: Statement re Rule 2.6 Extension

In accordance with Rule 2.6(c) of the Code, at the request of the Directors of Sativa, the Panel on Takeovers & Mergers (the “Panel”) has consented to an extension of the relevant deadline, until 5:00 p.m. on 3 June 2020 to enable the parties to complete the compilation…

ANNOUNCEMENT: Statement regarding possible offer

Sativa Group Plc [NEX: SATI], the UK’s leading quoted CBD wellness and medicinal cannabis Group, confirms that is has today entered into a letter of intent (“LOI”) with StillCanna, Inc, (“StillCanna”), regarding a possible offer for the Company…